Scandinavian Journal of Gastroenterology · 2015 · 25 citations · 26 references
MedicineInternal MedicinePathologyAnatomic PathologyHepatologyHistopathologyAutoimmune DiseasesBiliary Tract DiseaseBiliary Tract DisordersHepatic PathologyHepatobiliary DiseaseHepatobiliary PathologyBile Duct DiseaseClinicopathological CorrelationLymphoid Follicle HyperplasiaLymphoplasmacytic InflammationPreoperative Diagnosis
AIMS: IgG4-related sclerosing cholangitis in extrahepatic bile ducts in the absence of autoimmune pancreatitis (AIP) is rare and is poorly studied. Herein, we present the clinicopathological features of four cases of IgG4-related sclerosing cholangitis. METHODS AND RESULTS: The clinicopathological features of IgG4-related sclerosing cholangitis were compared with those of IgG4-related sclerosing cholangitis with AIP (n = 7), extrahepatic cholangiocarcinoma (n = 29), primary sclerosing cholangitis (n = 40), and secondary sclerosing cholangitis (n = 12). Several histomorphologic features distinguish IgG4-related sclerosing cholangitis, including a marked degree of bile duct injury, a higher percentage of lymphoid follicle formation, a higher percentage of perineuritis, and a more diffuse and dense lymphoplasmacytic infiltrate. All four cases of IgG4-related sclerosing cholangitis occurred exclusively in males. Of these cases, none had IgG4 serology checked preoperatively, and all had a preoperative diagnosis of extrahepatic cholangiocarcinoma. Clinical follow-up was available in 2 patients with a mean time of 11 months. Follow-up confirmed the benign course of the disease as the patients showed no evidence of relapse. IgG4-related conditions, including sclerosing cholecystitis and retroperitoneal fibrosis, were noted in three patients. CONCLUSIONS: IgG4-related sclerosing cholangitis in the absence of AIP presents as a distinct and under-recognized disease that mimics extrahepatic cholangiocarcinoma clinically. Awareness of this entity is essential to avoid erroneously diagnosing malignancy. The current threshold of 10 IgG4-positive plasma cells/high-power field (HPF) in the biopsy is not specific enough to exclude cholangiocarcinoma. Therefore, we suggest the diagnostic cut-off to be 50 IgG4-positive plasma cells/HPF in the biopsy.
26
High Serum IgG4 Concentrations in Patients with Sclerosing Pancreatitis
Hideaki Hamano, Shigeyuki Kawa, Akira Horiuchi et al. · New England Journal of Medicine · 2001 · 2.7K citations · Full text
Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011
Hisanori Umehara, Kazuichi Okazaki, Yasufumi Masaki et al. · Modern Rheumatology · 2012 · 1.7K citations
Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011
Hisanori Umehara, Kazuichi Okazaki, Yasufumi Masaki et al. · Modern Rheumatology · 2012 · 1.6K citations
A new clinicopathological entity of IgG4-related autoimmune disease
Terumi Kamisawa, Nobuaki Funata, Yukiko Hayashi et al. · Journal of Gastroenterology · 2003 · 1.5K citations
Life Sciences, Immunology, Pathology +14